TransEnterix is currently developing a patient-side robotic system called the SurgiBot® System. The system is designed to be controlled directly by the surgeon, with enhanced vision and robotic motion. SurgiBot System design incorporates deployment of flexible instruments and a high-definition 3D articulating scope through a single incision.
The SurgiBot System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States.
April 16, 2015
TransEnterix Announces Completion of GLP Studies
April 02, 2015
Developing A Surgical Robotics System That Doctors Really Want — And Hospitals Can Afford
April 08, 2015
TransEnterix, Inc. to Host Analyst Event
February 24, 2015
TransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2014